Table 1 The primary cancer location and staging range of the 531 volunteers with cancer included in Phase II of the Cerumen Project (sample size increase).
From: Cerumenogram as an assay for the metabolic diagnosis of precancer, cancer, and cancer remission
Local of primary cancer | Number of samples | Stage groups (I–IV) |
|---|---|---|
Colorectal, prostate, and bladder | 210 | I–IV |
Breast | 73 | I–IV |
Hematological | 42 | NI |
Skin | 40 | I–IV |
Head and Neck | 37 | II–IV |
Ovarian, uterine, and cervical | 36 | I–IV |
Stomach, esophagus and pancreas | 30 | I–IV |
Lung | 17 | III–IV |
Liver | 14 | I–III |
Kidney | 12 | I, III–IV |
Testicular | 6 | I–II, IV |
Soft tissue | 5 | NI |
Not Informed (NI) | 9 | – |
